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Background
Approximately 20% of HIV-1 infected breastfeeding
mothers transmit virus to their infants. It has been
hypothesized that dendritic cells expressing C-type lectins,
such as DC-SIGN, play an important role in the establish-
ment of infection with HIV-1 and several other pathogens.
Within our laboratory we have identified that Bile Salt
Stimulated Lipase (BSSL) is able to bind to DC-SIGN and
block HIV-1 transmission via dendritic cells. The C-termi-
nal part of BSSL contains a highly polymorphic repeat sec-
tion coded by exon 11 of the gene and is composed of an
array of 11 amino acid repeats.
Materials and methods
We have studied a large number of human milk samples
from HIV-1 negative mothers. The BSSL protein was ana-
lyzed by size fractionation and iso-electric focusing. We
studied the genomic structure of the gene through PCR
amplification and sequencing of the BSSL repeats for a
group of selected mothers.
Results
Milk samples from a large number of different mothers
(n=25) were identified that demonstrated variant levels of
inhibition to viral transfer. We have studied specific BSSL
genotypic as well as phenotypic properties in order to
identify what provides for the large variation of milk bind-
ing DC-SIGN. The tested milk samples were divided into
weak binding and strong binding groups based on their
DC-SIGN binding capacity. When comparing the PCR
results for the BSSL repeat number we identified a link
between the number of repeat domains and inhibition,
with the more repeats binding less efficiently. A selection
of weak and strong binders with identical repeat numbers
was also made. Sequencing of this selected group revealed
a mutation in the repeat section of an extreme weak
binder on an interesting position with regards to BSSL gly-
cosylation. Further analysis at the proteomic level was per-
formed with a higher molecular mass for BSSL in the weak
binding group being identified. Analysis of the DIGE
results showed a shift in pI of BSSL in the weak binding
group for 3 out of 5 cases.
Conclusions
Our results demonstrate that multiple factors contribute
to the differential binding of human milk to DC-SIGN.
Variation in the DC-SIGN binding capacities of BSSL may
provide for alterations in transmission patterns of patho-
gens or in altering the immune mediated responses
mounted in children against milk-borne pathogens. Fur-
thermore, understanding these differences in BSSL could
aide in the development of new agents aimed at prevent-
ing pathogen transmission across a mucosal barrier.
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